Clinical Research Directory
Browse clinical research sites, groups, and studies.
Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery
Sponsor: IWK Health Centre
Summary
This research trial will measure how useful Aprepitant is in preventing nausea and vomiting in children having surgery to correct scoliosis (curvature of the spine).
Official title: A Randomized Controlled Trial Comparing Aprepitant to Standard of Care for Postoperative Nausea and Vomiting Prophylaxis in Children and Adolescents Undergoing Scoliosis Surgery: The APRE-PONV Trial
Key Details
Gender
All
Age Range
8 Years - 19 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-03-17
Completion Date
2027-09
Last Updated
2025-03-25
Healthy Volunteers
No
Interventions
Aprepitant
Two doses of 40mg (2ml) Aprepitant. One to be given on the morning of surgery and the second on the morning of post-op day 1
Placebo
Two doses of dextrose syrup (2ml). One to be given on the morning of surgery and the second on the morning of post-op day 1
Locations (1)
IWK Health Sciences Center
Halifax, Nova Scotia, Canada